LDL-Lowering Tied to Lower First CVD Events in Patients 70+

People 70 years of age and older taking LDL cholesterol-lowering therapy for primary prevention have the same reduction in major vascular events as their younger counterparts, new research confirms.

Related Keywords

Copenhagen ,Køavn ,Denmark ,Danish ,Safiu Khan ,Novo Nordisk ,Vascular Center ,Department Of Epidemiology Research ,Journal Of The American College Cardiology ,Houston Methodist Debakey Heart ,Niklas Worm Andersson ,Epidemiology Research ,Statens Serum Institut ,American College ,Tine Lovs ,Lipids ,Ipid Management ,Cv ,Ardiovascular ,Low Ldl Cholesterol ,Ypobetalipoproteinemia ,Ow Low Density Lipoprotein Cholesterol ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Heart Disease ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Blood ,Body Mass Index Bmi ,Cardiovascular Disease ,Vd Cardi ,